Drug Shortage Report for ABSTRAL
| Report ID | 10448 |
| Drug Identification Number | 02364220 |
| Brand name | ABSTRAL |
| Common or Proper name | FENTANYL |
| Company Name | PALADIN PHARMA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | FENTANYL |
| Strength(s) | 800MCG |
| Dosage form(s) | TABLET |
| Route of administration | SUBLINGUAL |
| Packaging size | 10 Tabs |
| ATC code | N02AB |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2015-11-27 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-06-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-11-30 | French | Compare |
| v3 | 2017-11-30 | English | Compare |
| v2 | 2017-05-16 | French | Compare |
| v1 | 2017-05-16 | English | Compare |
Showing 1 to 4 of 4